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Summary  The  widespread  development  of  cell-phones  entails  novel  user  exposure  to  electro-
magnetic ﬁelds.  Health  impact  is  a  public  health  issue  and  a  source  of  anxiety  in  the  population.
Some clinical  studies  reported  an  association  between  cell  and  cordless  phone  use  and  vestibular
schwannoma;  others  found  none.  A  systematic  review  was  performed  of  all  published  clini-
cal studies  (cohort,  registry,  case-control  and  validation  studies),  with  analysis  of  results,  to
determine  the  nature  of  the  association  and  the  level  of  evidence.  Cohort  studies  were  incon-
clusive due  to  short  exposure  durations  and  poor  representativeness.  Registry  studies  showed
no correlation  between  evolution  of  cell-phone  use  and  incidence  of  vestibular  schwannoma.
Case-control  studies  reported  contradictory  results,  with  methodological  ﬂaws.  Only  a  small
number of  subjects  were  included  in  long-term  studies  (>  10  years),  and  these  failed  to  demon-
strate any  indisputable  causal  relationship.  Exposure  assessment  methods  were  debatable,  and
long-term  assessment  was  lacking.  An  on-going  prospective  study  should  determine  any  major
effect of  electromagnetic  ﬁelds;  schwannoma  being  a  rare  pathology,  absence  of  association
will be  difﬁcult  to  prove.  No  clinical  association  has  been  demonstrated  between  cell  and  cord-
less phone  use  and  vestibular  schwannoma.  Existing  studies  are  limited  by  their  retrospective
assessment  of  exposure.
©  2013  Elsevier  Masson  SAS.  All  rights  reserved.
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pIntroduction
Ionizing  radiation  is  presently  the  one  established  oncogenic
factor  in  sporadic  vestibular  schwannoma  [1,2].  Other  fac-
tors,  however,  are  discussed,  including  electromagnetic  ﬁeld
exposure.Cell-phones  and  cordless  phones,  which  release  an
electromagnetic  ﬁeld  close  to  the  head,  might  be  oncogenic
and  are  a  source  of  public  health  concern.  Their  use  has
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http://dx.doi.org/10.1016/j.anorl.2012.05.005ncreased  exponentially  over  the  last  10  years:  according
o  the  International  Telecommunication  Union,  4  billion
ubscriptions  had  been  taken  out  by  the  end  of  2008,  repre-
enting  60%  of  the  world  population;  there  were  61.4  million
ubscriptions  in  France  in  2009,  concerning  95.8%  of  the
opulation,  71%  of  12-  to  14-year-old  and  95%  of  15-  to
7-year-old  [3,4].  In  the  discussion,  inﬂaming  a  society  still
nder  the  trauma  of  recent  health  scandals,  expert  opinions
truggle  to  defend  either  a scientiﬁc  hypothesis  or  powerful
conomic  lobbies  (protection  against  electromagnetic
elds,  cell-phone  network  operators.  .  .).
The  present  critical  analysis  of  the  literature  addresses
he  question  as  to  whether  there  exists  an  association
served.
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etween  cell  and  cordless  phone  use  and  sporadic  forms  of
estibular  schwannoma.
aterial and method
 systematic  review  was  undertaken  of  the  French  and
nternational  scientiﬁc  literature  on  cell  and  cord-
ess  phone  use  and  vestibular  schwannoma,  using
he  PubMed  (www.ncbi.nlm.nih.gov)  and  Cochrane
http://www.cochrane.org/)  databases.  Four  categories  of
eywords  were  deﬁned  and  crossed,  based  on  the  MeSH
atabase:
 pathology:  neoplasms,  nervous  system  neoplasms,  acous-
tic  neuroma;
 intervention  factor:  cellular  phone,  telecommunication;
 type  of  study:  case-control  studies,  meta-analyses,
registries;
 and  methodological  limitations:  bias,  mental  recall.
The  searches  of  PubMed  and  Cochrane  retrieved
2  references,  from  which  studies  were  categorized  by
ype:  two  cohort  studies  [5,6];  four  registry  studies  [7—10];
3  articles  on  case-control  studies  [11—34];  ﬁve  meta-
nalyses  [35—39];  and  eight  validation  studies  [40—47].
Each  report  was  assessed  in  terms  of  type  of  study,  sam-
le  size,  group  homogeneity,  and  quality  of  description  of
ntervention  factor  exposure  (notably,  durations  and  inter-
als).
Conﬂicts  of  interest  were  also  examined,  in  terms  of
eclared  ﬁnancing  of  research.
esults
ohort  studies
he  study  by  Johansen  et  al.  [5]  included  450,000  Danish  cell
nd  cordless  phone  users  (including  150,000  analogic  phone
sers),  and  failed  to  ﬁnd  an  association  between  cell-phone
se  and  vestibular  schwannoma.
The  study  had  numerous  limitations.  Exposure  time
as  short:  less  than  4  years  for  92%  of  users  and  less
han  2  years  for  69%.  Mean  follow-up  was  only  3.1  years.
xposure  was  approximated  from  the  number  of  years’
ubscription  according  to  the  contracts,  rather  than  the
umulative  duration  of  calls.  Corporate  subscriptions  were
ot  included,  resulting  in  200,000  out  of  723,000  subscribers
eing  excluded.  Only  private  calls  were  thus  taken  into
ccount,  to  the  exclusion  of  intensive  business  use.  Finally,
here  existed  a  conﬂict  of  interest,  the  study  being  ﬁnanced
y  telecoms  operators.
Rothman  et  al.’s  cohort  study  (1996)  [6]  likewise  found
o  excess  mortality  in  cell-phone  users;  the  methodological
imitations,  however,  were  also  similar.
egistry  studieselson  et  al.  [7]  used  the  national  cancer  registries  of  Eng-
and  and  of  Wales  to  inventory  acoustic  neuroma  for  the
eriod  1979—2001.  They  reported  increased  incidence,  in
t
(
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ine  with  American  [8]  and  Danish  studies  [9].  For  the  period
990—1997,  the  increase  mainly  consisted  in  the  discovery
f  small  intra-canal  neuromas  by  new  diagnostic  imaging
echniques  (CT  and  MRI),  and  the  fall  in  incidence  after
997  may  have  been  due  to  exhaustion  of  this  ‘‘reserve’’
f  infraclinical  neuromas.
Inskip  et  al.  [10],  in  a  more  recent  registry  study  for
he  period  1992—2006,  found  no  correlation  between  the
volution  of  cerebral  tumor  and  of  cell-phone  use.
ase-control  studies
wo  types  of  case-control  study  are  to  be  distinguished:  early
linical  studies  with  small  samples  and  short  follow-up,  and
he  INTERPHONE  study  and  those  by  Hardell  et  al.,  which
ad  larger  study  populations  and  longer  follow-up.
irst  clinical  studies
uscat  et  al.’s  case  control  study  [11,12]  included
0  patients  and  86  controls.  Relative  risk  was  0.9  (p  =  0.07),
ith  no  signiﬁcant  variation  according  to  frequency,  dura-
ion  or  cumulative  time  of  cell-phone  use.  Tumors  were
ainly  contralateral  to  the  usual  side  of  phone-use.
Duration  of  use,  however,  was  less  than  6  years,  and
ess  than  2  years  in  90%  of  cases.  Ninety-seven  percent  of
he  study  population  had  less  than  60  hours’  cumulative
xposure  per  year.  The  small  sample  and  short  exposure
revented  ruling  out  an  association.
Inskip  et  al.  [13]  compared  96  brain  tumor  cases  to  a  con-
rol  group  of  799  hospital  patients.  Relative  risk  on  odds  ratio
as  1.4  with  95%  conﬁdence  intervals  of  0.6  and  3.5.  No
orrelation  was  found  between  side  of  phone-use  and  tumor
ide  (RR  =  0.9;  p  =  0.63).
The  study  involved  several  limitations.  Using  hospital
atients  as  controls  impaired  representativeness.  Cell-
hone  use  among  those  who  were  users  was  low,  with  few
22  out  of  96)  regular  users  and  only  ﬁve  with  at  least  5  years’
se.  Finally,  side  of  phone-use  and  tumor  side  was  analyzed
n  a  very  small  sample:  14  patients  with  at  least  6  months’
xposure.
he  INTERPHONE  and  Hardell  et  al.  studies
he  international  INTERPHONE  study  [14—21]  recruited
everal  teams,  coordinated  by  the  International  Agency  for
esearch  on  Cancer,  with  a  common  basic  protocol  [22].
ata  were  collected  by  interview  in  hospital  shortly  after
iagnosis.
Hardell  et  al.  [23—34]  studied  130  cases  and  900  controls
ver  a  6-year  period  from  1997  to  2003.  Data  were  collected
y  mail  2  months  after  surgery.  The  study  had  the  origi-
ality  of  including  cordless  phone  use  and  of  distinguishing
etween  1st  and  2nd  generation  cell-phones.  A  question-
aire  was  used  to  limit  interpretation  and  suggestion  bias.
he  response  rate  was  very  high  (about  90%  for  cases  and
ontrols),  ensuring  representativeness.
These  studies  had  divergent  ﬁndings.
None  of  the  INTERPHONE  studies  reported  an  associa-
ion  between  cell-phone  use  and  vestibular  schwannoma
Table  1).  Schoemaker  et  al.  [14]  reported  results  from  most
f  the  countries  involved  in  the  study.
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Table  1  Synopsis  of  INTERPHONE  studies.
Study  Country  n  cases  n  controls  OR  Conﬁdence  interval
Lönn  et  al.2004  [16]  Sweden  89  356  0.8  0.5—1.4
Christensen  et  al.,  2004  [15]  Denmark  45  97  0.9  0.5—1.6
Schoemaker  et  al.,  2005  [14]  Denmark,  Finland,
Sweden,  Norway,  UK
360  1.934  0.9  0.7—1.1
Takebayashi  et  al.,  2006  [19] Japan  51  192  0.7  0.4—1.2
Klaboe et  al.,  2007  [51] Norway  22  227  0.5  0.2—1.0
Schlehofer et  al.,  2007  [17] Germany  29  74  0.7 0.4—1.2
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The  study  was  run  from  1999  to  2004,  with  678  cases  and
3553  controls,  and  is  the  largest  case-control  study  on  the
subject.  It  found  no  signiﬁcant  relation  between  cell-phone
use  and  onset  of  neuroma,  whether  globally  or  in  subgroups
with  high  exposure  in  terms  of  duration  of  use  or  cumulative
use  (Fig.  1).
Neuromas,  however,  were  signiﬁcantly  more  frequently
on  the  side  of  phone-use  after  10  years’  exposure  (n  =  23;
controls  =  72;  OR  =  1.8;  95%  CI,  1.1—3.1),  although  the
authors  attributed  little  importance  to  this  barely  signiﬁcant
ﬁnding.
Hardell  et  al.  [28]  (Fig.  2)  reported  a  signiﬁcantly
increased  risk  of  tumor  associated  with  more  than  10  years’
(RR  =  2.9;  95%  CI,  1.6—5.5)  or  1000  hours’  (RR  =  2.2;  95%  CI,
1.4—3.4)  cordless  and/or  cell-phone  use.  The  proportion  of
tumors  directly  attributable  to  cordless  or  cell-phone  use
was  20.4%  (n  =  50  cases;  95%  CI,  13—77%).  There  was  also  a
strong  association  between  analogic  phone  use  and  acoustic
neuroma,  even  with  less  than  500  hours’  use.
Both  studies  involved  methodological  limitations.
In  the  INTERPHONE  study,  cell-phone  use  was  deﬁned
broadly,  as  at  least  one  call  per  week  for  at  least  6  months,
t
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Figure  1  Partial  results  of  the  INTERPHONE  study,  from  Denmark,  F
interval and  numbers  per  exposure  subgroup.
Schoemaker  e58  123  0.9 0.5—1.6
nd  the  subgroup  of  regular  and  longstanding  users  was
mall:  only  127  or  the  678  cases  had  used  a  cell-phone  for
ore  than  5  years  in  Shoemaker  et  al.’s  report.  Data  were
ollected  by  interview,  with  a  risk  of  inﬂuence  and  inter-
retation  bias.  The  multicenter  design,  with  a  large  number
f  interviewers,  impaired  homogeneity  and  thus  statistical
ower.  Control  response  rates  were  low,  with  less  than  50%  of
reselected  subjects  ﬁnally  included.  Control  subject  selec-
ion  criteria  varied  between  countries  (physicians’  registers,
ublic  registers,  etc.),  again  impairing  power.
The  type  of  phone  (analogic  or  digital)  was  not  recorded,
nd  exposure  to  other  similar  electromagnetic  ﬁelds  (cord-
ess  DECT  phones)  was  not  taken  into  account.
In  Hardell  et  al.’s  study  [24],  subjects  with  more  than
00  hours’  use  were  few:  13  ‘‘analogic’’  and  22  ‘‘digital’’
ases;  conﬁdence  intervals  were  thus  wide,  with  marginal
igniﬁcance  despite  a  high  odds  ratio.
Cases  and  controls  were  not  matched  geographically,  and
he  high  response  rate  suggests  forced  participation,  with  a
isk  of  inexact  or  false  replies.
Double  exposure  (cell  and  cordless  phones)  was  not  taken
nto  account  in  risk  calculation.
inland,  Norway,  UK  and  Sweden.  Odds  ratio  and  95%  conﬁdence
t  al.  [14]
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The  results,  moreover,  were  inconsistent.  Risk  was
lready  signiﬁcant  with  low  exposure  (<  5  years)  for  ana-
ogic  and  digital  mobile  phones  and  for  cordless  phones.  In
ubjects  with  less  than  5  years’  use,  risk  was  higher  with
ower  (<  64  hours)  than  higher  (>  64  hours)  use-level.  Finally,
he  results  pointed  to  a  signiﬁcant  association  between  cell-
hone  use  and  contralateral  tumor.
eta-analyses
here  were  ﬁve  meta-analyses.
The  ﬁrst  part  of  Hardell  et  al.’s  2008  meta-analysis  [35]
Tables  2  and  3)  covered  nine  case-control  studies  comparing
isk  in  users  and  non-users.  The  odds  ratio  showed  no
ssociation  between  cell-phone  use  and  acoustic  neuroma.The  methodology  took  account  of  the  lack  of  homogene-
ty  in  risk  measurement,  using  a  random  effects  model,  since
he  deﬁnition  of  both  user  and  exposure  varied  between
tudies.
a
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Table  2  Nine  case-control  studies  of  overall  association  betwee
et al.’s  meta-analysis  [35].
Study,  author,  date,  country  n  cases  
Inskip  et  al.,  2001  [13],  USA  40  
Lönn et  al.,  2004  [16],  Sweden  89  
Christensen  et  al.,  2004  [15],
Denmark
45  
Schoemaker  et  al.,  2005  [14],
Denmark,  Finland,  Sweden,
Norway,  Scotland,  UK
360  
Hardell et  al.,  2006  [24],
Sweden
130  
Takebayashi  et  al.,  2006  [19],
Japan
51  
Klaboe et  al.,  2007,  Norway  22  
Schlehofer et  al.,  2007  [17],
Germany
29  
Hours et  al.,  2007  [18],  France  58  
Meta-analysis  824  
OR: odds ratio; 95% CI: 95% conﬁdence interval.dds  ratio,  95%  CI  and  numbers.
l.  [28]
The  second  part  focused  on  subjects  with  more  than
0  years’  use.  It  covered  four  studies  and  found  a  barely  sig-
iﬁcant  risk  (95%  CI,  1.1—5.3)  of  ipsilateral  neuroma  after
t  least  10  years’  cell-phone  use.
Kan  et  al.’s  2008  meta-analysis  [36]  also  used  a  ran-
om  effects  model.  It  excluded  Hardell  et  al.’s  data,  on
he  grounds  that  including  cordless  phones  (DECT)  precluded
omogeneity.  Inskip  et  al.’s  data  were  included,  although,
s  pointed  out  above,  the  user  group  had  very  low  risk  expo-
ure.  Other  studies  were  not  included  (INTERPHONE  group).
he  risk  assessed  was  global,  regardless  of  laterality.
The  authors  concluded  that  no  signiﬁcant  association
btained.
Khurana  et  al.’s  2009  meta-analysis  [37]  focused  on
he  association  between  cell-phone  use  and  neuroma
fter  10  years’  exposure.  The  studies  analyzed  were  the
ame  as  in  Hardell  et  al.’s  meta-analysis,  but  with  a
ifferent  methodology,  using  a  ﬁxed  effect  model  requiring
omogeneous  measurements:  i.e.,  identical  theoretic  odds
n  cell-phone  use  and  vestibular  schwannoma,  with  Hardell
n  controls  OR  95%  CI
358  0.8  0.5—1.4
356  1  0.6—1.5
97  0.9  0.5—1.6
1934  0.9  0.7—1.1
900  1.7  1.2—2.3
192  0.7  0.4—1.2
227  0.5  0.2—1.0
74  0.7  0.4—1.2
123  0.9  0.5—1.6
4261  0.9  0.7—1.1
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Table  3  Four  case-control  studies  of  association  between  cell-phone  use  exceeding  10  years  and  vestibular  schwannoma,  with
Hardell et  al.’s  meta-analysis  [35].
Study,  author,  date,
country,  latency
Total  Ipsilateral  Contralateral
n  cases/
controls
OR  95%  CI  n  cases/
controls
OR  95%  CI  n  cases/
controls
OR  95%  CI
Lönn  et  al.,  2004  [16],
Sweden
≥  10  years
14/29  1.8  0.8—4.3  12/15  3.9  1.6—9.5  4/17
Christensen et  al.,  2004
[15],  Denmark
≥  10  years
2/15  0.2  0.04—1.1  —/—  —  —  —/—  —  —
Schoemaker  et  al.,  2005
[14],  Denmark,
Finland,  Sweden,
Norway,  Scotland,  UK
≥  10  years
47/212  1  0.7—1.5  31/124  1.3  0.8—2.0  20/105  1  0.6—1.7
Hardell et  al.,  2006  [24],
Sweden
≥ 10  years
20/99 2.9 1.6—5.5 10/28  3.5  1.5—7.8  6/29  2.4  0.9—6.3
Meta-analysis  83/355  1.3  0.6—2.8  53/167  2.4  1.1—5.3  30/151  1.2  0.7—2.2
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aOR: odds ratio; 95% CI: 95% conﬁdence interval.
ratio;  however,  as  pointed  out  above,  these  studies  varied
in  user  classiﬁcation  criteria,  and  cannot  be  considered
homogeneous.
The  conclusion  was  similar  to  Hardell  et  al.’s:  a  signiﬁcant
association  between  subjects  with  at  least  10  years’  cell-
phone  use  and  ipsilateral  tumor.
Lahkola  et  al.’s  meta-analysis  [38]  used  much  the  same
ﬁxed  effects  methodology,  and  found  no  signiﬁcant  associa-
tion.
Myung  et  al.’s  meta-analysis  [39]  looked  at  the  overall
relation  between  cerebral  tumor  and  cell-phone  use.  Using
the  Newcastle-Ottawa  Scale  (NOS)  to  assess  case-control
study  quality  in  meta-analyses,  the  authors  found  a  signiﬁ-
cant  association  between  cell-phone  use  and  cerebral  tumor
risk  in  low-bias  studies;  these  were  almost  exclusively  (7
out  of  8)  those  by  Hardell  et  al.  A  meta-analysis  based  on
reports  from  a  single  team  requires  cautious  interpretation:
Myung  et  al.  provided  no  speciﬁc  ﬁndings  in  regard  to  acous-
tic  neuroma,  but  did  illustrate  the  difﬁculties  of  interpreting
a  meta-analysis.
Discussion
Various  types  of  study  have  been  published  on  the  associa-
tion  between  cell-phone  use  and  vestibular  schwannoma.
The  registry  studies  fail  to  conﬁrm  or  rule  out  a  link,  and
merely  rule  out  any  major  effect.
The  more  robust  case-control  studies  (INTERPHONE  and
Hardell  et  al.)  agree  on  the  absence  of  association  between
less  than  10  years’  use  of  a  digital  phone  and  tumor  onset.
For  periods  exceeding  10  years’  use,  sample  sizes  were  too
small  to  demonstrate  any  clearly  signiﬁcant  association,  and
the  authors  dispute  the  interpretation  to  be  put  on  the  data.
Finally,  none  of  the  ﬁve  meta-analyses  were  methodolog-
ically  rigorous  or  satisfactorily  answered  the  question  as  to
a
n
a clinical  link.  Results  were  barely  signiﬁcant  and  founded
n  disparate  studies.
In  all,  the  case-control  studies  were  the  most  informa-
ive,  given  the  low  incidence  of  vestibular  schwannoma  in
he  general  population.  The  contradictory  analyses  founded
n  their  results  can  be  explained  by  limitations  in  interpre-
ation  due  to  their  retrospective  designs  and  the  problems
f  measuring  exposure.
Non-response  has  been  shown  to  be  a factor  reducing
dds  ratios  [40],  and  this  may  account  for  some  of  the
iscrepancy  between  the  INTERPHONE  studies,  with  low
esponse  rates,  and  those  of  Hardell  et  al.,  where  response
ates  were  high.
In  these  studies,  cell-phone  use  was  estimated  retrospec-
ively.
Assessment  of  call-time  seems  to  be  a  good  indicator
f  real  phone  use,  according  to  Samkange-Zeeb  et  al.  [41]
nd  Funch  et  al.  [42]. It  remains,  however,  only  an  approx-
mation,  subject  to  memory  bias.  Hours  et  al.  reported  a
eproductible  discrepancy  between  real  phone  use  (mea-
ured  from  operator  data)  and  self-declared  use  [43].  The
iscrepancy  is  variable,  increasing  with  level  of  use,  but  is
lready  signiﬁcant  in  retrospective  assessment  of  less  than
 months’  use,  and  weakened  the  power  of  Vrijheid  et  al.’s
tudy  [44]. Up  to  a 30%  reduction  in  odds  ratio  was  calculated
or  the  INTERPHONE  study.
Only  one  study  [45]  provided  reliable  data  on  the  reliabil-
ty  of  retrospective  assessment  of  side  of  use  in  both  healthy
nd  vestibular  schwannoma  subjects:  the  latter,  inﬂuenced
y  the  diagnosis  of  tumor,  tend  to  blame  their  cell-phone
nd  to  overestimate  phone  use  on  the  affected  side.Signiﬁcance  levels  in  the  case-control  studies  were  low,
nd  interpretation  should  bear  in  mind  the  approximate
ature  of  the  correlation  between  the  results  as  reported
nd  reality.
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Electromagnetic  ﬁeld  exposure  is  the  physiopathological
actor  put  forward  to  explain  the  possible  oncogenic  effects
f  cell-phone  use.  The  cell  phone  is  a  cordless  and  mobile
elecommunication  system  using  radiocommunication
etween  the  relay  antennae  of  the  cell-phone  network,
ith  transmission  to  the  landline  network;  it  is  thus  a
ource  of  radioelectric  waves  (also  called  radio  waves  or
ertzian  waves),  creating  a  novel  exposure  of  users  to
lectromagnetic  radiation.
The  radioelectric  waves  used  in  telephone  communi-
ation  are  low-frequency  (300  MHz  to  3  GHz)  non-ionizing
lectromagnetic  waves,  the  close  ﬁeld  intensity  of  which
s  measured  as  the  speciﬁc  absorption  rate  (SAR).  In
ell-phones,  the  SAR  is  less  than  à  2  W/kg,  which  is  an
nfrathermal  level  (i.e.,  <  4  W/kg),  as  conﬁrmed  on  in  vivo
ssessment  [46].
Two  types  of  biological  impact  have  been  described  for
he  electromagnetic  radiation  (300  MHz  to  3  GHz)  involved
n  cell-phones:  thermal  effects  as  of  4  W/kg  and,  contro-
ersially,  non-thermal  effects  due  to  electromagnetic  ﬁeld
xposure  as  such.
Most  reports  studied  electromagnetic  exposure  in  terms
f  phone  use;  none  reported  data  for  SAR.  SAR,  however,
aries  considerably  from  one  phone  to  another  and  according
o  conditions  of  use  (urban  or  rural).  These  variations  in  SAR
ave  been  quantiﬁed  [47],  with  emission  power  varying  2-  or
-fold  from  one  country  to  another  under  similar  conditions
f  use.
None  of  the  studies  mentioned  the  model  of  cell-phone
eing  used  or  its  conditions  of  use  —  which  once  again
estiﬁes  to  the  approximate  nature  of  reported  exposure
ssessments.
onclusions and perspectives
he  development  of  a  tumor  induced  by  a  carcinogen
equires  repeated  and  lasting  exposure  to  progressively
vercome  antitumor  mechanisms.  There  is  thus  a  minimum
pstream  exposure  time  before  onset  of  any  cell  deregula-
ion.  Subsequently,  there  is  then  a  period  of  latency,  varying
ccording  to  tumor  evolution,  before  diagnosis.  Schwan-
omas  are  slow  growing.  The  combination  of  these  two
echanisms  accounts  for  the  interval  between  exposure
o  a  carcinogen  (cigarette  smoke,  UV  radiation,  alcohol,
sbestos,  ionizing  radiation,  etc.)  and  tumor  diagnosis.  Con-
ersely,  tumor  onset  within  5  years  of  initial  exposure  is
mprobable.
Mass  use  of  cell-phones  is  a  recent  phenomenon  (in  1997,
nly  10%  of  the  French  population  were  active  users),  as
s  preponderant  or  exclusive  use  of  cell-phones.  There  are
hus  few  users  with  longstanding  (>  10  years)  intensive  use,
nd  it  is  not  sure  that  a  causal  relationship  can  presently
e  demonstrated  in  such  a  population,  even  though  cell-
hone  networks  have  been  in  existence  for  longer  in  certain
ountries,  such  as  Japan  and  Sweden.
Moreover,  reported  results  suffer  from  the  retrospective
ature  of  their  exposure  assessments  and  the  lack  of  any
ong-term  study.
Case-control  studies  should  be  continued  as  a  watch  pro-
ram,  to  discover  any  link  that  may  exist.  Given,  however,
he  rate  at  which  cell-phone  use  has  spread  (reaching  80%E.  Mornet  et  al.
n  France  in  2008),  control  groups  will  soon  be  lacking,  and
ith  them  any  possibility  of  demonstrating  a  link.
Is  a  prospective  study  feasible?  Low  schwannoma  inci-
ence  requires  large-scale  recruitment  and  the  possibility
f  reliably  and  durably  assessing  individual  exposure.  The
OSMOS  study  [48]  was  launched  recently  and  is  intended
o  follow  up  a cohort  of  250,000  subjects  in  ﬁve  northern
uropean  countries  for  a  period  of  25  years.  Exposure  will
e  measured  from  operator  data.  The  main  limitation  of  this
mbitious  project  is  that  it,  to  be  able  to  demonstrate  any
ffect,  it  will  require  not  less  than  a  3-  to  7-fold  elevation
f  risk  of  vestibular  schwannoma.  Moreover,  data  for  side  of
se  and  SAR  will  be  collected  indirectly.  This  study  would  be
apable  of  demonstrating  a major  effect  of  electromagnetic
eld,  but  will  not  be  able  to  detect  any  risk  less  than  3  to  1.
The  increase  in  the  incidence  of  cerebral  tumor  [49]  calls
or  exploration  of  environmental  factors.  Electromagnetic
elds  are  one  line  of  investigation,  among  many  others,  for
linical  and  epidemiological  studies.
The  study  of  the  clinical  impact  of  cell-phone  use  suffers
resently  from  the  lack  of  long-term  follow-up  in  a  large-
cale  population  and  of  reliable  quantiﬁcation  of  exposure.
uture  studies  will  have  to  address  these  issues.  Data  on
umor  size  and  evolutivity  have  seldom  been  provided,  but
ould  enable  assessment  of  the  infraclinical  phase  and  of
he  possible  implication  of  cell-phones  in  evolutivity  of  pre-
xisting  tumors.
In the  years  to  come,  clinical  studies  will  run  up  against
he  generalization  of  cell-phone  use  and  exposure  to  other
ources  of  radiation  (Wi-Fi,  bluetooth,  etc.)  that  are  difﬁcult
o  measure.  As  the  population  of  non-users  virtually  disap-
ears,  exposure  assessment  will  have  to  be  more  precise  id
ny  effect  is  to  be  detected.
Only  a  long  and  costly  cohort  study  will  be  able  to  reduce
ias.  Its  results  will  be  open  to  criticism,  and  not  available
ntil  2025—2030.  What  is  to  be  done  meanwhile?  However
mperfect,  the  ﬁrst  clinical  studies  should  be  enough  to
ive  the  public  reasonable  reassurance  as  to  the  absence
f  any  major  effect.  In  vitro  studies,  moreover,  have  not
hown  any  genotoxicity  associated  with  electromagnetic
elds  [50].
Finally,  it  is  to  be  borne  in  mind  that  no  clinical  studies
ave  demonstrated  an  association  between  non-ionizing
lectromagnetic  radiation  exposure  and  any  benign  or  malig-
ant  human  pathology.  Results  from  glioma  studies  have
een  discordant,  and  no  syndrome  of  hypersensitivity  to
lectromagnetic  ﬁelds  has  been  scientiﬁcally  demonstrated.
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